Market Research Report: Micro Labs Ltd.

Company Overview

Name, Mission of the Company

Micro Labs Limited
Mission: "To provide quality medicines throughout the world at affordable prices."

Founding and Key People

Founded: 1973

Founder: Shri G.C. Surana

Key People:

Dilip Surana, Chairman & Managing Director

Anand Surana, Director

Diya Surana, Head of Corporate Affairs

Headquarters

Location: Bangalore, India

Number of Employees

Total Employees: No information is available

Revenue

Annual Revenue: Over Rs 4,000 crore (as of Forbes India report 2021)

Notable Accreditations

FDA-US

MHRA-UK

What the Company is Known For

Micro Labs Ltd. is known for its pharmaceutical products spanning several therapeutic areas including Cardiology, Diabetology, Pain Management, Dermatology, Ophthalmology, and Neurology. It is particularly renowned for Dolo-650.

Products

Key Products

1. Dolo-650

Type: Paracetamol tablet

Description: Used for fever and pain management

Key Features: Contains 650 mg paracetamol, preferred prescription for high fever

2. Trisopt

Type: Ophthalmic suspension

Description: A fixed-dose combination of Brimonidine, Timolol, and Brinzolamide for glaucoma management

Key Features: World's first triple drug combo for glaucoma

3. Other Notable Products

Amlong

Lubrex

Diapride

Vildapride

Olmat

Avas

Tripride

Bactoclav

Tenepride-M

Arbitel

Product Description

The company offers over 400 products, including:

Fever & Pain Management

Anti-hypertensives

Lipid agents

Diabetes management

Antibiotics

Ophthalmology products

Key Features

Development of innovative and patented drugs

Focus on generic and branded pharmaceutical products

Several products approved by FDA-US and MHRA-UK

Recent Developments

New Products Launched

Trisopt: The world’s first triple drug fixed-dose combination for glaucoma management.

Awards and Recognitions

2023: Dolo ranked No. 1 brand in Paracetamol solids as per IQVIA MAT March 2023.

2021: Frost & Sullivan Award for manufacturing excellence.

2019: CMD Mr. Dilip Surana awarded ‘Responsible Business Leader Award 2019’ by Responsible Business Awards.

2020: PR Leadership Awards and Best Patent Awards for contributions to the field of patents.

New Features and Partnerships

Increased Production: Due to the COVID-19 pandemic, manufacturing of Dolo-650 was scaled up significantly.

Fever Foundation: Focused on fever research and education, involving top doctors for better understanding and treatment of fever.

Global Expansion: Presence in over 50 countries, with significant operations in 25 countries including the USA, Europe, and Africa.

Additional Information

Manufacturing Facilities: Total of 14 manufacturing plants including specialized facilities for API, penicillin, and non-penicillin products.

Research & Development: Strong R&D focus with over 400 scientists working on pharmaceutical formulations, drug delivery systems, and bio-equivalence studies.

API Unit: Built over 24,000 square meters, complying with cGMP requirements.

Social Impact and CSR Activities

Contributions towards education through scholarships and financial aid.

Social welfare activities including disaster relief and healthcare support.

Environmental sustainability initiatives such as the plastic cleanup drive for World Earth Day 2024.

This comprehensive report outlines the core aspects of Micro Labs Ltd., reflecting their market position, product offerings, recent developments, and continued commitment to providing quality healthcare solutions globally.